Closed
SectorHealthcare
460.96 0.16
24h
Min
446.15
Max
461.19
Income | -8.8M -66M |
---|---|
Sales | 180M 774M |
Profit margin | -8.566 |
Employees | 2,230 |
EBITDA | 7.4M 19M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | -0.09% downside |
Next Earnings | 30 paź 2025 |
---|
Market Cap | 16B 59B |
---|---|
Previous open | 460.8 |
Previous close | 460.96 |
By Acuity
50%
50%
149 / 371 Ranking in Healthcare
By Trading Central
Confidence
Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 460.22 USD -0.09%
High 583 USD
Low 290 USD
Based on 27 Wall Street analysts offering 12 month price targets forAlnylam Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$